GlassScriptPhysician profile
Vincent James Caracciolo
NPI 1952446908
$6,567.44
in general payments reported to CMS, 2019-2025
46 companies · $767 in 2025
The $767 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $1,207 · 2021: $786 · 2022: $1,270 · 2023: $980 · 2024: $649 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $718.94 | 2019-2024 | Xarelto |
| Pfizer INC. | $489.94 | 2019-2025 | |
| Medtronic, INC. | $483.49 | 2021-2024 | Linq II, Onyx Frontier |
| Sanofi-Aventis U.S. LLC | $409.69 | 2019-2023 | |
| Amgen INC. | $396.07 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $368.00 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $361.16 | 2019-2025 | Camzyos |
| Merck Sharp & Dohme LLC | $360.79 | 2021-2024 | Verquvo |
| Boston Scientific Corporation | $296.11 | 2022-2025 | Watchman Flx, Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor |
| Cvrx, INC. | $227.19 | 2022-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.88 | 2019-2025 | Jardiance |
| Biotronik INC. | $150.31 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $146.05 | 2025 | Assure Wcd |
| Amarin Pharma, INC. | $144.84 | 2019-2021 | |
| Abiomed | $139.67 | 2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Caracciolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.